Gut microbiota plays a crucial role in human health and disease. The alterations in the composition of gut microbiota may cause the onset of certain human pathologies. One of these is Alzheimer’s disease (AD). High-fat diets, administration of antibiotics, lack of probiotics and/or prebiotics in diet increase the risk of AD. On the other hand, modulation of the composition of gut microbiota may decrease the risk of AD and be able to slow down the progression of AD.
TilgH, MoschenAR (2014) Microbiota and diabetes: An evolving relationship. Gut63, 1513–1521.
2.
LeyRE, PetersonDA, GordonJI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell124, 837–848.
3.
Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature486, 207–214.
4.
SchroederBO, BäckhedF (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med22, 1079–1089.
5.
Muñoz-GarachA, Diaz-PerdigonesC, TinahonesFJ (2016) Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr63, 560–568.
6.
SekirovI, RusselSL, AntunesCM, FinlayBB (2010) Gut microbiota in health and disease. Physiol Rev90, 859–904.
7.
Moreno-IndiasI, CardonaF, TinahonesFJ, Queipo-OrtuñoMI (2014) Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol6, 190.
8.
KobozievI, WebbCR, FurrKL, GrishamMB (2014) Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med68, 122–133.
9.
Dominiguez-BelloMG, CostelloEK, ContrerasM, MargrisH, HidalgoG, FiererN, KnightR (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A107, 11971–11975.
10.
ZetendalEG, Rajilic-StojanovicM, VosWM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut57, 1605–1615.
11.
MakinoH, KushiroA, IshikawaE, KubotaH, GawadA, SakaiT, OishiK, MartinR, Ben-AmorK, KnolJ, TanakaR (2013) Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant’s microbiota. PLoS One8, e78331.
12.
MunyakaPM, KhafipourE, GhalaJE (2014) External influence of early childhood establishment of gut microbiota and subsequent health implications. Font Pediatr2, 109.
13.
Pozo-RubioT, MujicoJR, MarcosA, PuertollanoE, NadalI, SanzY, NovaE (2011) Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system. Br J Nutr106, 1216–1223.
14.
BennoY, SawadaK, MitsuokaT (1984) The intestinal microflora of infants: Composition of fecal flora in breast-fed and bottle-fed infants. Microbial Immunol28, 975–986.
15.
De FillippoC, CavalieriD, Di PaolaM, RamazottiM, PoulletJB, MassartS, ColliniS, PieracciniG, LionettiP (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A107, 14691–14696.
16.
OriachCS, RobertsonRC, SantonC, CryanJF, DinanTG (2016) Food for thought: The role of nutrition in the microbiota-gut-barrier-axis. Clin Nutr Exp6, 25–38.
17.
WalshCJ, GuinaneCM, O’ToolePW, CotterPD (2014) Beneficial modulation of the gut microbiota. FEBS Lett588, 4120–4130.
18.
CleassonMJ, JefferyIB, CondeS, PowerSE, O’ConnorEM, CusackS, HarrisHM, CoakleyM, LakshminarayananB, O’SullivanO, FitzgeraldGF, DeaneJ, O’ConnorM, HarnedyN, O’ConnorK, O’MahonyD, van SinderenD, WallaceM, BrennanL, StantonC, MarchesiJR, FitzgeraldAP, ShanahanF, HillC, RossRP, O’ToolePW (2012) Gut Microbiota composition correlates with diet and health in the elderly. Nature488, 178–184.
19.
JernbergC, LöfmarkS, EdlungC, JanssonJK (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology156, 3216–3223.
20.
DethlefsenL, RelmanDA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A108, 4554–4561.
21.
PendersJ, ThijsC, VinkC, StelmaFF, SnijdersB, KummerlingI, van den BrandtPA, StobberinghEF (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics118, 511–521.
22.
MurphyEF, CotterPD, HoganA, O’SullivanO, JoyceA, FouchyF, ClarkeSF, MarguesTM, O’TollePW, StantonC, QuigleyEM, DabyC, RossPR, O’DohertyRM, ShanahanF (2013) Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut62, 220–226.
23.
DethlefsenL, HuseS, SoginML, RelmanDA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol6, 2383–2400.
HviidA, SvanstromH (2009) Antibiotic use and intussusception in early childhood. J Antimicrobiol Chemother64, 642–648.
26.
IapichinoG, CallegariML, MarzoratiS, CigadaM, CorbellaD, FerrariS, MorelliL (2008) Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol57, 1007–1014.
ForslundK, HildebrandF, NielsenT, FalonyG, Le ChatelierE, SunagawaS, PriftiE, Vieira-SilvaS, GudmundsdottirV, PedersenHK, ArumugamM, KristiansenK, VoigtAY, VestergaardK, HenogR, CosteaPI, KultimaJR, LiJ, JørgsenT, LevenezF, DoreJ, MetaHIT consortium, NielsenHB, BrunakS, RaesJ, HansenT, WangJ, EhrlichSD, BorkP, PedersenO (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature528, 262–266.
29.
WuH, EsteveE, TremaroliV, KhanMT, CesarR, Mannerås-HolmL, StåhlmanM, OlssonLM, Planas-FèlixM, XifraG, MercaderJM, TorrentsD, BurcelinR, RicartW, PerkinsR, Fernàndez-RealJM, BäckhedF (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med23, 850–858.
30.
ChapmanC, GibsonG, RowlandI (2011) Health benefits of probiotics: Are mixtures more effective than single strains. Eur J Nutr50, 1–17.
31.
PokrzywnickaP, GumprechtJ (2016) Intestinal microbiota and its relationship with diabetes and obesity. Clin Diabetol5, 164–172.
YadovH, JainS, SinhaPR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition23, 62–68.
34.
GibsonGR, RoberfroidMB (1995) Dietary modulation of the human colonic microbiota; introducing the concept of prebiotics. J Nutr125, 1401–1412.
35.
MeyerD, Stasse-WolthuisM (2009) The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr125, 1277–1289.
36.
DavisL, MartínezI, WalterJ, GoinC, HutkinsRW (2011) Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One6, e25200.
37.
StrowskiMZ, WiedenmannB (2009) Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases. Gut58, 1044–1045.
38.
CaniPD, BibiloniR, KnaufC, WagetA, NeyrinckAM, DelzenneNM, BurcelinR (2008) Changes in gut microbiota, metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes57, 1470–1481.
39.
CaniPD, LecourtE, DewulfEM, SohetFM, PachikianBD, NaslainD, De BackerF, NeyrinckAM, DelzenneNM (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr90, 1236–1243.
40.
Queipo-OrtuñoMI, Bodo-OrdoóñezM, MuriM, Gomez-ZumagueroJM, Clemente-PostigoM, EstruchR, Cardona DiazF, Andrés-LacuevaC, TinahonesFJ (2012) Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr95, 1323–1334.
41.
Clemente-PostigoM, Queipo-OrtuñoMI, Bodo-OrdoñezM, Coin-AragüezL, Roca-RodriguezMM, Delgado-ListaJ, CardonaF, Andres-LacuevaC, TinahonesFJ (2013) Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations. Am J Clin Nutr97, 1053–1061.
42.
CaniPD, NeyrinckAM, FavaF, KnaufC, BurcelinRG, TuohyKM, GibsonGR, DelzenneNM (2007) Selective increases of bifidobacterial in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia50, 2374–2383.
43.
ErridgeC, AttinaT, SpickettCM, WebbDJ (2007) A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr86, 1286–1292.
44.
CreelySJ, McTernanPG, KusminskiCM, FisherFM, Da SilvaNF, KhanolkarM, EvansM, HarteAL, KumarS (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab292, E740–E747.
45.
CaniPD, DelzenneNM (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des15, 1546–1558.
46.
FestiD, SchiumeriniR, EusebiLH, MarascoG, TaddiaM, ColecchiaA (2014) Gut microbiota and metabolic syndrome. World J Gastroenterol20, 16079–16094.
47.
TurnbaughPJ, HamadyM, YatsunenkoT, DuncanA, LeyRE, SoginML, JonesWJ, RoeBA, AffourtitJP, EgholmM, HenrissatB, HeathAC, KnightR, GorfonJL (2009) A core gut microbiome in obese and lean twins. Nature457, 480–484.
48.
MussoG, GambinoR, CassaderM (2010) Obesity, diabetes and gut microbiota. The hygiene hypothesis expanded?Diabetes Care33, 2270–2284.
49.
KaurN, ChenCC, LutherJ, KaoJY (2011) Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes2, 211–216.
50.
AllinKH, NielsenT, PedersenO (2015) Gut microbiota in patients with type 2 diabetes. Eur Endocrinol172, R167–R177.
51.
BaothmanOA, ZamzamiMA, TaherI, AbubakerJ, Abu-FarhaM (2016) The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis15, 108.
52.
MunroN (2016) Gut microbiota: Its role in diabetes and obesity. Diab Primary Care18, 1–6.
53.
WangL, ChristophersenCT, SorichMJ, GerberJP, AngleyMT, ConlonMA (2011) Low relative abundances of the mucolytic bacterium Ackermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol77, 6718–6721.
DickersonFB, StallingsC, OrigoniA, KatsafansE, SavageCL, SchweinfurthLA, GogaJ, KhushalaniS, YolkenRH (2014) Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: A randomized, placebo-controlled trial. Prim Care Companion CNS Disord16, pii: PCC. 13m01579.
56.
JiangH, LiangZ, ZhangY, MaoH, MaZ, YinY, WangW, TangW, TanZ, ShiJ, LiL, RuanB (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun48, 186–194.
57.
BelkaidY, HandTW (2014) Role of the microbiota in immunity and inflammation. Cell157, 121–141.
58.
JiangC, LiG, HuangP, LiuZ, ZhaoB (2017) The gut microbiota and Alzheimer’s disease. J Alzheimers Dis58, 1–15.
59.
MulakA, BonazB (2015) Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol21, 10609–10620.
60.
WangB, YaoM, LvL, LingZ, LiL (2017) The human microbiota in health and disease. Engineering3, 71–82.
61.
ClarkA, MachN (2016) Exercise-induced stress behavior, gut-microbiota-brain axis and diet: A systemic review for athletes. J Int Soc Sports Nutr13, 43.
62.
CeniMC, SanzY, Codoñer-FranchP (2017) Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol23, 5486–5498.
63.
FallucaF, PorrataC, FallucaS, PianesiM (2014) Influence of diet on gut microbiota, inflammation and type 2 diabetes. First experience with macrobiotic Ma-Pi 2 diet. Diabet Metab Res Rev30(Suppl 1), 48–54.
64.
WongJM, de SouzaR, KendallCW, EmamA, JenkinsDJ (2006) Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol40, 235–243.
65.
DuncanSH, LouisP, ThomsonJM, FlintHJ (2009) The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol11, 2112–2122.
66.
LarsenN, VogensenFK, van den BergFW, NielsenDS, AndreasenAS, PedersenBK, Al-SoudWA, SørensenSJ, HansenLH, JakobsenM (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLos One5, e9085.
67.
ShanahanF, MurphyE (2011) The hybrid science of diet, microbes, and metabolic health. Am J Clin Nutr94, 1–2.
68.
SamuelBS, ShaitoA, MotoikeT, ReyFE, BackhedF, ManchesterJK, HammerRE, WilliamsSC, CrowleyJ, YanagisawaM, GordonJL (2008) Effects of gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A105, 16767–16772.
69.
BraheLK, AstrupA, LarsenIH (2013) Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?Obes Rev14, 950–959.
LiouAP, PaziukM, LuevanoJMJr, MachineniS, TurnbaughPJ, KaplanLM (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med5, 178ra41.
72.
SonnenburgJL, BäckhedF (2016) Diet-microbiota interactions as mediators of human metabolism. Nature235, 56–64.
73.
ThorburnAN, McKenzieCI, ShenS, StanleyD, MaciaL, MasonLJ, RobertsLK, WongCH, ShimR, RobertR, ChevalierN, TanJK, MariñoE, MooreRJ, WongL, McConvilleMJ, TullDJ, WoodLG, MurphyVE, MattesJ, GibsonPG, MackayCR (2015) Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun6, 7320.
74.
DavieJR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr133, 2485S–2493S.
75.
SchilderinkR, VerseijdenC, de JongeWJ (2013) Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol4, 226.
76.
AtarashiK, TanoueT, ShimaT, ImaokoA, KuwaharaT, MomoseY, ChengG, YamasakiS, SaitoT, OhbaY, TaniguchiT, TakedaK, HoriS, IvanowII, UmesakiY, ItohK, HondaK (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Nature331, 337–341.
77.
MaslowskiKM, VieiraAT, NgA, KranichJ, SierroF, YuD, SchillerHC, RolphMS, MackayF, ArtisD, XavierRJ, TeixeiraMM, MackayCR (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature461, 1282–1286.
SchuijtTJ, LankelmaJM, SciclunaBP, de Sousa e MeloF, RoelofsJJ, de BoerJD, HoogendijkAJ, de BeerR, HoogendijkAJ, de BeerR, de VosA, BelzerC, de VosWM, van der PollT, WiersingaWJ (2016) The gut microbiota plays a protective role in the host defense against pneumococcal pneumonia. Gut65, 575–583.
MidtvedtT (1974) Microbial bile acid transformation. Am J Clin Nutr27, 1341–1347.
82.
KawamataY, FujiiR, HosovaM, HaradaM, YoshidaH, MiwaM, FukusumiS, HabataY, ItohT, ShintaniY, HinumaS, FujisawaY, FujinoM (2003) A G protein-coupled receptor responsive to bile acids. J Biol Chem278, 9435–9440.
83.
SayinSI, WahlströmA, FelinJ, JänttiS, MarschallHU, BambergK, AngelinB, HyötyläinenT, OrešičM, BäckhedF (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab17, 225–235.
84.
BarrettE, RossR, O’TooleP, FitzgeraldG, StantonC (2012) γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol113, 411–417.
85.
ReigstadCS, SalmonsonCE, RaineyJF, SzurszewskiJH, LindenDR, SonnenbergJL, FarrugiaG, KashyaoPC (2015) Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J29, 1395–1403.
86.
CryanJF, DinanTG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behavior. Nat Rev Neurosci13, 701–712.
87.
LiuX, CaoS, ZhangX (2015) Modulation of gut microbiota-brain axis by probiotics, prebiotics and diet. J Agric Food Chem63, 7885–7895.
88.
GallandL (2014) The gut microbiome and the brain. J Med Food17, 1261–1272.
89.
RiederR, WisniewskiPJ, AldermanBL, CampbellSC (2017) Microbes and mental health: A review. Brain Behav Immun66, 9–17.
90.
PetraAI, PanagiotidouS, HatziagelakiE, StewartJM, ContiP, TheoharidesTC (2015) Gut-microbiota-brain axis and effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther37, 984–995.
91.
MayerEA, KnightR, MazmanianSK, CryanJF, TillischK (2014) Gut microbes and the brain: aradigm shift in neuroscience. J Neurosci34, 15490–15496 .
92.
MayerEA, TillishK, GuptaA (2015) Gut/brain axis and the microbiota. J Clin Invest125, 926–938.
93.
LeungK, ThuretS (2015) Gut microbiota: A modulator of brain plasticity and cognitive function in ageing. Healthcare3, 898–916.
94.
BudzyńskiJ, KłopockaM (2014) Brain-gut axis in the pathogenesis of Helicobacter pylori infection. World J Gastroenterol20, 5212–5225.
95.
CaniPD, KnaufC (2016) How gut microbiota talk to organs: The role of endocrine and nervous routes. Mol Metab5, 743–752.
96.
Van CauwenbergheC, Van BraeckhovenC, SleegersK (2015) The genetic landscape of Alzheimer disease: Clinical implications and perspectives. Gen Med18, 421–430.
97.
ChakrabartiS, KhemkaVK, BanerjeeA, ChatterjeeG, GangulyA, BiswasA (2015) Metabolic risk factors of sporadic Alzheimer’s disease: Implications in the pathology, pathogenesis and treatment. Aging Dis6, 282–299.
98.
ChuLW (2012) Alzheimer’s disease: Early diagnosis and treatment. Hong Kong Med J18, 228–237.
99.
SunX, ChenW, WangY (2015) β-Amyloid: The key peptide in the pathogenesis of Alzheimer’s disease. Front Pharmacol6, 1–9.
AlexandrovPN, PogueA, BhattacharjeeS, LukiwWJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer’s disease. Neuroreport22, 623–627.
103.
O’BrienRJ, WongPC (2011) Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci34, 185–204.
104.
BhattacharjeeS, LukiwWJ (2013) Alzheimer’s disease and the microbiome. Front Cell Neurosci7, 153.
105.
HillJM, BhattacharjeeS, PogueAI, LukiwWJ (2014) The gastrointestinal tract microbiome and potential link to Alzheimer’s disease. Front Neurol5, 1–4.
106.
LanctotKL, HerrmannN, MazzottaP, KhanLR, IngberN (2004) GABAergic function in Alzheimer’s disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can J Psychiat49, 439–453.
107.
SolasM, PuertaE, RamirezMJ (2015) Treatment options in Alzheimer’s disease: The GABA story. Curr Pharm21, 4960–4971.
108.
YanoJM, YuK, DonaldsonGP, ShastriGG, AnnP, MaL, NaglerCR, IsmagilovRF, MazmanianSK, HsiaoEY (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell161, 264–276.
109.
CirritoJR, DisabatoBM, RestivoJL, VergesDK, GoebelWD, SathyanA, HayrehD, D’AngeloG, BenzingerT, YoomH, KimJ, MorrisJC, MintunMA, ShelineYJ (2011) Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A108, 14968–14973.
110.
LakhanSE, CaroM, HadzimichalisN (2013) NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry4, 52.
111.
NeufeldKM, KangN, BienestackJ, FosterJA (2011) Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil23, 255–264.
112.
WangT, HuX, LiangS, LiW, WuX, WangL, JinF (2015) Lactobacillus fermentum restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes6, 707–717.
113.
SchwartzK, BolesBR (2013) Microbial amyloids – functions and interactions within the host. Curr Opin Microbiol16, 93–99.
114.
MulliganVK, ChakrabarttyA (2013) Protein misfolding in the late-onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis. Proteins81, 1285–1303.
115.
CoxPA, DavisDA, MashDC, MetcalfJS, BanackSA (2016) Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proc Biol Sci283, 20152397.
116.
BrennerSR (2013) Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as beta-N-methylamino-L-alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson-Dementia-Complex in humans and equine motor neuron disease in horses. Med Hypotheses80, 103–108.
117.
HuX, WangT, JinF (2013) Alzheimer’s disease and gut microbiota. Sci China Life Sci59, 1006–1023.
118.
GareauMG, WineE, RodriguesDM, ChoJH, WharyMT, PhilpottDJ, Mac QuenG, ShermanPM (2011) Bacterial infection causes stress-induced memory dysfunction in mice. Gut60, 307–317.
119.
ClarkeG, GrenhamS, ScullyP, FitzgeraldP, MoloneyRD, StanhanF, DinanTG, CryanJF (2013) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry18, 666–673.
120.
Diez HeijtzR, WangS, AnuarF, QianY, BjorkholmB, SamuelssonA, HibberdML, ForssbergH, PetterssonS (2011) Normal gut microbiota modulates brain development and behavior. Pro Natl Acad Sci U S A108, 3047–3052.
121.
CarlinoD, De VannaM, TongiorgiE (2013) Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?Neuroscientist19, 345–353.
122.
HillJM, LukiwWJ (2015) Microbial-generated amyloids and Alzheimer’s disease (AD). Front Aging Neurosci7, 9.
123.
GeraldHC, Dreses-WerringloerU, WildtKS, DekaS, OszustC, BalinBJ, FreyWH, BordayoEZ, Whittum-HudsonJA, HudsonAP (2006) Chlamydiophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol Med Microbiol48, 355–366.
124.
KountourasJ, BozikiM, ZavosC, GavalasE, Giartza-TaxidouE, VenizelosI, DeretziG, GrigoriadisN, TsiaousiE, VardakaE (2012) A potential impact of chronic Helicobacter pylori infection on Alzheimer’s disease pathology and course. Neurobiol Aging33, e3–e4.
125.
KountourasJ, GavalasE, ZavosC, StergiopoulosC, ChatzopoulocC, KapetanakisN, GisakisD (2007) Alzheimer’s disease andinfection: Defective immune regulated and apoptosis as proposed common links. Med Hypotheses68, 368–388.
126.
PrandotaJ (2014) Possible link between toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am J Alzheimers Dis29, 205–214.
127.
BallMJ (1982) Limbic predilection in Alzheimer dementia: Is relative herpes virus involved. Can J Neurol9, 303–306.
128.
WozniakMA, MeeAP, ItzhakiRF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer’s amyloid plaques. J Pathol217, 131–138.
129.
WideraM, KleinAN, CinarY, FunkeSA, WillboldD, SchaalH (2014) The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity. AIDS Res Ther11, 1.
130.
LurainNS, HansonBA, MartinsonJ, LeurgansSE, LandayAL, BennettDA, SchneiderJA (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis208, 564–572.
131.
ChiuWC, TsanYT, TsaiSL, ChangCJ, WangJD, ChenPC, Health Data Analysis in Taiwan Research Group (2014) Hepatitis C viral infection and the risk of dementia. Eur J Neurol21, 1068e59.
ZhangC, LiS, YangL, HuangP, LiW, WangS, ZhaoG, ZhangM, PangX, YanZ, LiuY, ZhaoL (2013) Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun4, 2163.
134.
KimMS, HwangSS, ParkEJ, BaeEJ (2013) Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ Microbiol Rep5, 765–775.
135.
ZimmerJ, LangeB, FrickJS, SauerH, ZimmermannK, SchwiertzA, RuschK, KlosterhalfenS, EnckP (2012) A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr66, 53–60.
136.
de La SerreCB, EllisC, LeeJ, HartmanAL, RutledgeJC, RaybouldHE (2010) Prosperity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol299, G440–G448.
137.
ChenD, YangZ, ChenX, HuangY, YinB, GuoF, ZhaoH, HuangJ, WuY, GuR (2014) Effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. BMC Complement Altern Med14, 386.
138.
KimKA, GuW, LeeIA, JohnEH, KimDH (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One7, e47713.
139.
HamiltonMK, BoudryG, LemayDG, RaybouldHE (2015) Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol308, G840–G851.
140.
HoldGL, SmithM, GrangeC, WattER, El-OmarEM, MukhopadhyaI (2014) Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?World J Gastroenterol20, 1192–1210.
141.
ParasharA, UdayabahanuM (2017) Gut microbiota: Implications in Parkinson’s disease. Parkin Rel Dis38, 1–7.
142.
RosenfeldCS (2015) Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos43, 1557–1571.
143.
RusselDW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem72, 137–174.
